Drug co-administration
TIM® Predicts the effect of co-administration of drugs
Predict the impact of ARAs
tiny-TIM’s was used to predict the impact of acid-reducing agents (ARAs) on oral drug absorption. Twelve development and approved compounds were tested, selected for their known susceptibility to ARAs due to their physicochemical properties. The effect of co-administration was assessed by comparing bioaccessibility under the standard fasted state protocol (gastric pH 3.0–1.5) versus a fasted state + ARA protocol, in which gastric acid secretion (HCl) was omitted to elevate gastric pH, simulating ARA-induced conditions.
Keywords
The results
- tiny-TIM reliably predicted whether or not ARAs impact drug bioavailability, even for salt forms and low doses
- Scale and directionality of ARA effect was successfully predicted and in agreement with in vivo results
- In addition to the extent of bioavailability, tiny-TIM was also able to capture the effect of ARA on rate of dissolution
- The commonly used risk indicator D0 showed limited ability to predict ARA effect for free bases, while tiny-TIM did offer predictive value
tiny-TIM is a very reliable and promising GI model to successfully predict the nature of DDI...
Full reference
Liu, J., Nagapudi, K., Dolton, M. J., & Chiang, P. C. (2021). Utilizing Tiny-TIM to Assess the Effect of Acid-Reducing Agents on the Absorption of Orally Administered Drugs. Journal of Pharmaceutical Sciences, 110(8), 3020–3026. https://doi.org/10.1016/j.xphs.2021.04.017
Get in contact
We are excited to hear what’s on your plate and how we can help you understand what happens to your product during digestion!